Ped AML 001abcd CHIP-AML22, MEC

Ped AML 004cdef CHIP-AML22, ADE

Ped AML 005cd NOPHO AML 2012, FLAD

Ped AML 006ab CHIP-AML22, HAM

Ped AML 007abcd CHIP-AML22, HA3E

Ped AML 008ab CHIP-AML22, FLA

Ped AML 009 Cytarabin ved leukocytose hos nyfødte med Down

Ped AML 010abc ML-DS 2007, AIE, kur 1

Ped AML 011ab ML-DS 2007, AI, kur 2

Ped AML 012ab ML-DS 2007, hAM, kur 3

Ped AML 013ab ML-DS 2007, HA , kur 4

Ped AML 018abcdf AML residiv MACE+GO (etoposid/etoposidfosfat)

Ped AML 019 APL Intratekal cytarabin alene ICC APL study 01

Ped AML 020a/020b Intratekal trippel NOPHO-DBH AML 2012/CHIP-AML22 metotreksat/cytarabin/prednisolon

Ped AML 021abcd AML (ALL) residiv CloEC Eto/klofarabin/syklofosfamid

Ped AML 022, 023, 024, 025 AML residiv FLAD-FLA

Ped AML 026ab Azacitidin iv, 75 mg/m2

Ped AML 027abcd GOCYT Cytarabin/gemtuzumab ozogamicin

Ped AML 028abcd Gemtuzumab ozogamicin (GO) 4,5 / 3 mg/m2

Ped AML 029 Intratekal trippel ICC APL study 02

Ped AML 030ab APL Arsentrioksid ICC APL study 02

Ped AML 033 AML res. Nederl. prot., Clo/cyt/dauno/it trippel

Ped AML 034abc-035 ITCC-101/APAL2020D FLA-GO/FLA sykl. 1-2

Ped AML 036 ITCC-101/APAL2020D Intratekal trippel

Ped AML 037 ITCC-101/APAL2020D Azacitidin

Ped AML 038abc AML res. FLA+GO

Ped AML 039ab Azacitidin iv post-SCTx, 36 mg/m2

Ped AML 041ab og ped AML 042ab CHIP-AML22, MEC del 1 m. etoposid (041) el. etopsidfosfat (042)

Ped AML 043abc CHIP-AML MEC-GO del 2, dag 8-12